Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Gene Therapy
Tianjin Medical University, Department of Immunology reports research in cancer gene therapy
August 12th, 2008
Current study results from the report, 'Effects of raf kinase inhibitor protein expression on metastasis and progression of human epithelial ovarian cancer,' have been published. "Loss of function of metastasis suppressor genes is an important step in the progression to a malignant tumor type. Studies in cell culture and animal models have suggested a role of Raf kinase inhibitor protein (RKIP) in suppressing the metastatic spread of prostate cancer, breast cancer, and melanoma cells," scientists in Tianjin, People's Republic of China report. "However, the function of RKIP in ovarian cancer (OVCA) has not been reported. To explore the potential role of RKIP in...
Source: Cancer Weekly (2008-08-12)
|
